https://orcid.org/0000-0002-5453-3166
References
- Weinberg OK, Arber DA. Mixed-phenotype acute leukemia: historical overview and a new definition. Leukemia. 2010;24(11):1844–1851.
- van den Ancker W, Terwijn M, Westers TM, et al. Acute leukemias of ambiguous lineage: diagnostic consequences of the WHO2008 classification. Leukemia. 2010;24(7):1392–1396.
- Yan L, Ping N, Zhu M, et al. Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification. Haematologica. 2012;97(11):1708–1712.
- Kashimura M, Minamihisamatsu M. Chromosomal rearrangement, t(12;22)(p13;q13), in acute myelomegakaryoblastic leukemia. Cancer Genet Cytogenet. 1993;65(1):81–82.
- Shiozaki H, Iwahashi C, Suzuki T, et al. [Acute myelofibrosis terminating in acute myelomegakaryoblastic leukemia]. Rinsho Ketsueki. 1989;30(10):1806–1809.
- Mariańska B, Apel D, Seferyńska I, et al. Niesklasyfikowany przewlekły zespół mieloproliferacyjny Ph(-); i(17q); +8 z transformacja mielo-megakarioblastyczna–opis przypadku [Unclassified chronic myeloproliferative Ph(-); i(17q); +8 syndrome with mixed myelo-megakaryoblastic crisis–case report. ]. Acta Haematol Pol. 1996;27(1):85–88.
- Aoyagi Y, Maeda M, Kanayama M, et al. Clinical and electron microscopic investigation of 3 cases of acute myelomegakaryocytic leukemia. Rinsho Ketsueki. 1987;28(6):857–864.
- Tallman MS, Neuberg D, Bennett JM, et al. Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience. Blood. 2000;96(7):2405–2411.
- Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405.